# Realloys Inc.: financial statements, quarterly

ALOY · Nasdaq · CIK 1567900 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aloy.md) · [Financials](/companies/aloy/financials.md) · [Filings](/companies/aloy/filings.md) · [Insiders](/companies/aloy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aloy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.7](/filings/0001437749-24-035252.md) | [0.8 d](/filings/0001437749-25-008773.md) | [0.6](/filings/0001437749-25-017091.md) | [0.7](/filings/0001437749-25-026916.md) | [0.6](/filings/0001437749-25-031175.md) | [0.6 d](/filings/0001437749-26-005114.md) | [0.0](/filings/0001628280-26-036966.md) | [0.4](/filings/0001628280-26-056817.md) | [0.7](/filings/0001437749-25-031175.md) | [0.6 d](/filings/0001437749-26-005114.md) | [0.7](/filings/0001628280-26-036966.md) | [0.8](/filings/0001628280-26-056817.md) |
| Cost of revenue | $m | [0.3](/filings/0001437749-24-035252.md) | [0.5 d](/filings/0001437749-25-008773.md) | [0.4](/filings/0001437749-25-017091.md) | [0.4](/filings/0001437749-25-026916.md) | [0.3](/filings/0001437749-25-031175.md) | [0.4 d](/filings/0001437749-26-005114.md) | [0.0](/filings/0001628280-26-036966.md) | [0.2](/filings/0001628280-26-056817.md) | [0.3](/filings/0001437749-25-031175.md) | [0.2 d](/filings/0001437749-26-005114.md) | [0.3](/filings/0001628280-26-036966.md) | [0.3](/filings/0001628280-26-056817.md) |
| Gross profit | $m | [0.4](/filings/0001437749-24-035252.md) | [0.3 d](/filings/0001437749-25-008773.md) | [0.3](/filings/0001437749-25-017091.md) | [0.3](/filings/0001437749-25-026916.md) | [0.4](/filings/0001437749-25-031175.md) | [0.2 d](/filings/0001437749-26-005114.md) | [0.2](/filings/0001437749-25-017091.md) | [0.2](/filings/0001437749-25-026916.md) | [0.4](/filings/0001437749-25-031175.md) | [0.4 d](/filings/0001437749-26-005114.md) | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.9](/filings/0001628280-26-036966.md) | [1.1](/filings/0001628280-26-056817.md) | not reported | not reported | [85.4](/filings/0001628280-26-036966.md) | [36.0](/filings/0001628280-26-056817.md) |
| Operating income | $m | [(0.9)](/filings/0001437749-24-035252.md) | [(1.1) d](/filings/0001437749-25-008773.md) | [(0.9)](/filings/0001437749-25-017091.md) | [(0.8)](/filings/0001437749-25-026916.md) | [(0.7)](/filings/0001437749-25-031175.md) | [(0.9) d](/filings/0001437749-26-005114.md) | [(0.9)](/filings/0001628280-26-036966.md) | [(0.9)](/filings/0001628280-26-056817.md) | [(0.4)](/filings/0001437749-25-031175.md) | [(1.6) d](/filings/0001437749-26-005114.md) | [(87.7)](/filings/0001628280-26-036966.md) | [(36.8)](/filings/0001628280-26-056817.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001628280-26-036966.md) | [0.1](/filings/0001628280-26-056817.md) | not reported | not reported | [0.0](/filings/0001628280-26-036966.md) | [0.0](/filings/0001628280-26-056817.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-035252.md) | [0.0 d](/filings/0001437749-25-008773.md) | [0.0](/filings/0001437749-25-017091.md) | [0.0](/filings/0001437749-25-026916.md) | [0.0](/filings/0001437749-25-031175.md) | [0.0 d](/filings/0001437749-26-005114.md) | [0.0](/filings/0001437749-25-017091.md) | [0.0](/filings/0001437749-25-026916.md) | [0.0](/filings/0001437749-25-031175.md) | [0.0 d](/filings/0001437749-26-005114.md) | not reported | not reported |
| Net income | $m | [(0.7)](/filings/0001437749-24-035252.md) | [(0.7) d](/filings/0001437749-25-008773.md) | [(0.9)](/filings/0001437749-25-031175.md) | [(0.9)](/filings/0001437749-25-031175.md) | [(0.8)](/filings/0001437749-25-031175.md) | [(0.9) d](/filings/0001437749-26-005114.md) | [(1.7)](/filings/0001628280-26-056817.md) | [(2.2)](/filings/0001628280-26-056817.md) | [(0.7)](/filings/0001437749-25-031175.md) | [(1.6) d](/filings/0001437749-26-005114.md) | [(107)](/filings/0001628280-26-036966.md) | [(36.8)](/filings/0001628280-26-056817.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001628280-26-036966.md) | [(0.05)](/filings/0001628280-26-056817.md) | not reported | not reported | [(1.98)](/filings/0001628280-26-036966.md) | [(0.59)](/filings/0001628280-26-056817.md) |
| Basic EPS | $ per share | [(0.21)](/filings/0001437749-24-035252.md) | not reported | [(0.27)](/filings/0001437749-25-017091.md) | [(0.27)](/filings/0001437749-25-026916.md) | [(0.22)](/filings/0001437749-25-031175.md) | not reported | [(0.05)](/filings/0001628280-26-036966.md) | [(0.05)](/filings/0001628280-26-056817.md) | [(0.19)](/filings/0001437749-25-031175.md) | not reported | [(1.98)](/filings/0001628280-26-036966.md) | [(0.59)](/filings/0001628280-26-056817.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001437749-23-031931.md) | [0.5](/filings/0001437749-25-008773.md) | [0.1](/filings/0001437749-24-017116.md) | [1.1](/filings/0001437749-24-027047.md) | [0.1](/filings/0001437749-24-035252.md) | [0.0](/filings/0001437749-26-005114.md) | [0.2](/filings/0001437749-25-017091.md) | [0.0](/filings/0001437749-25-026916.md) | [0.1](/filings/0001437749-25-031175.md) | [2.8](/filings/0001628280-26-056817.md) | [42.5](/filings/0001628280-26-036966.md) | [122](/filings/0001628280-26-056817.md) |
| Current assets | $m | [0.8](/filings/0001437749-23-031931.md) | [1.0](/filings/0001437749-25-008773.md) | [0.2](/filings/0001437749-24-017116.md) | [1.1](/filings/0001437749-24-027047.md) | [1.2](/filings/0001437749-24-035252.md) | [1.2](/filings/0001437749-26-005114.md) | [1.5](/filings/0001437749-25-017091.md) | [1.2](/filings/0001437749-25-026916.md) | [0.2](/filings/0001437749-25-031175.md) | [38.5](/filings/0001628280-26-056817.md) | [73.5](/filings/0001628280-26-036966.md) | [154](/filings/0001628280-26-056817.md) |
| Total assets | $m | [9.6](/filings/0001437749-23-031931.md) | [9.8](/filings/0001437749-25-008773.md) | [9.0](/filings/0001437749-24-017116.md) | [9.9](/filings/0001437749-24-027047.md) | [10.0](/filings/0001437749-24-035252.md) | [9.9](/filings/0001437749-26-005114.md) | [10.2](/filings/0001437749-25-017091.md) | [9.9](/filings/0001437749-25-026916.md) | [8.8](/filings/0001437749-25-031175.md) | [93.4](/filings/0001628280-26-056817.md) | [130](/filings/0001628280-26-036966.md) | [210](/filings/0001628280-26-056817.md) |
| Current liabilities | $m | [1.5](/filings/0001437749-23-031931.md) | [2.2](/filings/0001437749-25-008773.md) | [2.2](/filings/0001437749-24-017116.md) | [3.8](/filings/0001437749-24-027047.md) | [3.4](/filings/0001437749-24-035252.md) | [4.3](/filings/0001437749-26-005114.md) | [5.4](/filings/0001437749-25-017091.md) | [6.1](/filings/0001437749-25-026916.md) | [3.9](/filings/0001437749-25-031175.md) | [7.2](/filings/0001628280-26-056817.md) | [14.6](/filings/0001628280-26-036966.md) | [5.0](/filings/0001628280-26-056817.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [56.0](/filings/0001628280-26-056817.md) | [28.9](/filings/0001628280-26-036966.md) | [19.2](/filings/0001628280-26-056817.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001628280-26-056817.md) | [0.2](/filings/0001628280-26-036966.md) | [0.0](/filings/0001628280-26-056817.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [7.9](/filings/0001437749-24-035252.md) | [7.3](/filings/0001437749-26-005114.md) | [6.5](/filings/0001437749-25-031175.md) | [5.8](/filings/0001437749-25-031175.md) | [6.3](/filings/0001437749-25-031175.md) | [(5.2)](/filings/0001628280-26-056817.md) | [(1.3)](/filings/0001628280-26-056817.md) | [(3.4)](/filings/0001628280-26-056817.md) | [4.8](/filings/0001437749-25-031175.md) | [35.8](/filings/0001628280-26-056817.md) | [102](/filings/0001628280-26-036966.md) | [191](/filings/0001628280-26-056817.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.5) d](/filings/0001437749-24-035252.md) | [0.0 d](/filings/0001437749-25-008773.md) | [(0.4)](/filings/0001437749-25-017091.md) | [(0.3) d](/filings/0001437749-25-026916.md) | [0.0 d](/filings/0001437749-25-031175.md) | [(0.0) d](/filings/0001437749-26-005114.md) | [(0.4)](/filings/0001628280-26-036966.md) | [(0.4) d](/filings/0001628280-26-056817.md) | [(1.9) d](/filings/0001437749-25-031175.md) | [(0.5) d](/filings/0001437749-26-005114.md) | [(10.6)](/filings/0001628280-26-036966.md) | [(7.2) d](/filings/0001628280-26-056817.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001437749-24-035252.md) | [0.0 d](/filings/0001437749-25-008773.md) | not reported | not reported | [0.0 d](/filings/0001437749-24-035252.md) | [0.0 d](/filings/0001437749-25-008773.md) | [0.0](/filings/0001628280-26-036966.md) | [0.0 d](/filings/0001628280-26-056817.md) | not reported | not reported | [0.0](/filings/0001628280-26-036966.md) | [0.0 d](/filings/0001628280-26-056817.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.6](/filings/0001437749-21-012445.md) | [13.5](/filings/0001437749-21-020157.md) | [13.8](/filings/0001437749-22-012678.md) | [8.6](/filings/0001437749-22-020437.md) | [9.7](/filings/0001437749-22-027277.md) | [13.2](/filings/0001437749-22-012678.md) | [13.2](/filings/0001437749-22-020437.md) | [13.2](/filings/0001437749-22-027277.md) | [32.6](/filings/0001628280-26-036966.md) | [41.3](/filings/0001628280-26-056817.md) | [54.0](/filings/0001628280-26-036966.md) | [62.1](/filings/0001628280-26-056817.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,987,642 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056817.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.